An interventional study of Alcoolpredict in Binge Drinking, sponsored by CHU de Reims. Completed at 1 site in France. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-21.
Sponsored by CHU de Reims · Not applicable, Interventional, and Health services research
The purpose of this study is to specify the psychological, cognitive, neuro-functional and genetic profile associated with binge drinker behaviors among young adults. Results will help identifying more precisely vulnerability factors associated with this pattern of alcohol consumption and guiding prevention efforts.
Binge drinking behavior is characterised by speed of drinking on a particular occasion, frequency of drunkenness during the most recent six month period, and the percentage of times getting drunk when drinking. The prevalence of weekly binge drinking among European Union drinkers in 2009 was reported to be 28% of the student population, and 33% among all young people aged 15-24. The consequences of this behavior are multiple and often dramatic, they include: academic failure, violent acts, rape, domestic or road accidents. The study aims to identify vulnerability factors associated with binge drinking. The protocol explores the psychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI) patterns associated with binge drinking behavior.
71 studies on the registry are indexed under Binge Drinking; 20 are open to participants now.
This study's enrollment of 125 is close to the median of 120 across 64 interventional studies indexed under Binge Drinking.
Browse Binge Drinking studies →CHU de Reims is the lead sponsor of 276 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
psychological (personality), neuropsychological (executive functions, memory), genetic (snp polymorphisms) and neuro-anatomical (fMRI)
Neuropsychological test : Mini International Neuropsychiatric Interview (M.I.N.I)
Time frame: day 1
Neuropsychological test : Wisconsin Card Sorting Test (WCST)
Time frame: V2(3 weeks later)
Genetics tests (Single Nucleotide Polymorphism)
Time frame: V2(3 weeks later)
MRI - signal BOLD (" Blood Oxygen Level Dependant ").
Time frame: V3(up to 2 month)
Neuropsychological test : Family Informant Schedule and Criteria (FISC)
Time frame: day 1
Neuropsychological test : Alcohol Use Questionnaire
Time frame: day 1
Neuropsychological test :Trail Making Test, partie A et B
Time frame: V3(up to 2 month)
Neuropsychological test : Plus/Minus Test
Time frame: V3(up to 2 month)
Neuropsychological test :Go/No-Go
Time frame: V3(up to 2 month)
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.